Changzheng Hospital — Shanghai, Shanghai Municipality

Public research footprint of Changzheng Hospital, compiled from the ClinicalTrials.gov public registry.

233

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Castration-resistant Prostate Cancer · Moderate to Severe Refractory Autoimmune Disease · Sjogren's Syndrome (SS) · Systemic Lupus Erythematosus (SLE)

Recently updated registry entries

NCT05438043 — A Study of Daratumumab (Active Not Recruiting)
NCT04557098 — A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (Active Not Recruiting)
NCT06238713 — Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Changzheng Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.